← All companies
HCAT
Health Catalyst, Inc.
$2.28
+0.07 +3.17%
Key statistics
from XBRL data in SEC filingsMarket cap
$168M
Revenue (TTM)
$302M
Net income (TTM)
-$265M
EPS (TTM)
$-3.73
P/E ratio
—
Dividend yield
—
Free cash flow
-$237K
Cash
$59.9M
Total assets
$412M
Gross margin
—
52-week range
$0.96 – $3.88
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Shareholder vote results
Jul 20, 2026
8-K
Entered a material agreement; Regulation FD disclosure
Jun 4, 2026
10-Q
Quarter ended 2026-03-31
May 11, 2026
8-K
Results of operations (earnings release)
May 11, 2026
10-K/A
Fiscal year ended 2025-12-31
Apr 30, 2026
8-K
Director or officer change; Regulation FD disclosure
Apr 30, 2026
8-K
Director or officer change; Other events
Apr 27, 2026
8-K
Director or officer change
Apr 3, 2026
10-K
Fiscal year ended 2025-12-31
Mar 12, 2026
8-K
Results of operations (earnings release)
Mar 12, 2026
8-K
Director or officer change; Regulation FD disclosure
Feb 18, 2026
8-K
Director or officer change
Jan 23, 2026
8-K
Results of operations (earnings release)
Jan 12, 2026
8-K
Entered a material agreement; Director or officer change; Regulation FD disclosure
Dec 2, 2025
10-Q
Quarter ended 2025-09-30
Nov 10, 2025
8-K
Results of operations (earnings release)
Nov 10, 2025
8-K
Director or officer change; Regulation FD disclosure
Sep 10, 2025
10-Q
Quarter ended 2025-06-30
Aug 8, 2025
8-K
Results of operations (earnings release); Director or officer change
Aug 7, 2025
8-K
Shareholder vote results
Jul 10, 2025
10-Q
Quarter ended 2025-03-31
May 9, 2025
8-K
Results of operations (earnings release)
May 7, 2025
10-K/A
Fiscal year ended 2024-12-31
Apr 30, 2025
10-K
Fiscal year ended 2024-12-31
Feb 26, 2025
8-K
Results of operations (earnings release); Director or officer change
Feb 26, 2025
8-K
Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure; Other events
Jan 13, 2025
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release); Unregistered sale of equity; Director or officer change; Other events
Nov 6, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 7, 2024
8-K
Entered a material agreement; Took on a direct financial obligation; Other events
Jul 18, 2024
8-K
Shareholder vote results
Jun 17, 2024
10-Q
Quarter ended 2024-03-31
May 10, 2024
8-K
Results of operations (earnings release)
May 9, 2024
10-K/A
Fiscal year ended 2023-12-31
Apr 23, 2024
10-K
Fiscal year ended 2023-12-31
Feb 22, 2024
8-K
Results of operations (earnings release); Director or officer change
Feb 22, 2024
8-K
Other events
Jan 8, 2024
10-Q
Quarter ended 2023-09-30
Nov 6, 2023
8-K
Results of operations (earnings release)
Nov 2, 2023